Because No One is Immune to the Law
March 24, 2020 - FDA, Medical Devices + Diagnostics, COVID-19, Product Liability + Class Action

Prep Act Declaration Emboldens Drug and Device Industry to Innovate In the Face Of a Growing Crisis

By: Erin M. Bosman and Julie Y. Park

OFCCP Issues National Interest Exemption for New Coronavirus Relief Contracts

COVID-19 is, quite literally, putting the medical supply industry to the test. Manufacturers are being pushed to develop novel products like therapies and vaccines to combat the disease as quickly as possible. The Public Readiness and Emergency Preparedness (PREP) Act encourages drug and medical device companies to increase production of existing products currently in short supply, and to develop new innovative COVID-19 therapies and treatments by limiting tort liability for the goods.

Read our Class Dismissed blog post.